Ovarian Epithelial Cancer - 24 Studies Found Not yet recruiting : Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France : Ovarian Epithelial Cancer : 2016-11-28 : Other: Patient with ovarian epithelial cancer Completed : Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer : Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer : 2001-05-06 : Biological: recombinant interleukin-12 Given intraperitoneally Withdrawn : Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression : Ovarian Carcinoma : 2008-04-10 : Drug: Fondaparinux Arixtra 2.5 mg by subcutaneous injection once daily for 8 weeks or until disease recu Recruiting : Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer : Ovarian Epithelial Cancer : 2017-03-04 : Drug: SPL-108 Subcutaneous injection of 150 mg administered either one time or two times per day. Active, not recruiting : Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma : Ovarian Neoplasms Ovarian Epithelial Cancer : 2014-04-04 : Biological: DCVAC/OvCa with Standard of Care Active, not recruiting : Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study : Ovarian Carcinoma : 2008-07-14 : Other: timing of surgery Surge Withdrawn : Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity : Recurrent Ovarian Carcinoma : 2009-07-17 : Drug: Cisplatin PLATINOL® Not yet recruiting : Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer : Epithelial Ovarian Cancer : 2012-09-04 Active, not recruiting : Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) : Ovarian Carcinoma : 2014-09-15 : Device: NovoTTF-100L(O) Patien Terminated : A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy : Epithelial Ovarian Cancer : 2013-03-18 : Drug: CAELYX CAELYX 50 mg per Next >>>
